| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5599379 | Atherosclerosis | 2017 | 9 Pages |
Abstract
These results strongly support the favourable benefit-to-risk ratio of K-877 add-on therapy in combination with statin treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote, Eiichi Araki, Hideki Suganami, Shun Ishibashi, on behalf of the K-877 Study Group on behalf of the K-877 Study Group,